Skip to Main Content
Contribute Try STAT+ Today

Hello, everyone, and how are you today? We are doing just fine, thank you, now that the Pharmalot campus has quieted down. The short person is hovering over a laptop and Mrs. Pharmalot has taken the spirited official mascot for a long constitutional. As a result, we have time to focus on the necessary tasks, such as brewing cups of stimulation and foraging for items of interest. On that note, here are a few tidbits. By the way, the STAT Summit is in full swing, so you may want to take a peak. In any event, we hope your day is productive and meaningful. And stay safe — wear a mask. …

Pfizer (PFE) launched a pilot delivery program for its experimental Covid-19 vaccine in four U.S. states, as the drug maker seeks to address distribution challenges stemming from its ultra-cold storage requirements, Reuters notes. Rhode Island, Texas, New Mexico, and Tennessee were picked due to their differences in overall size, diversity of populations, immunization infrastructure, and urban and rural settings. The four states will not receive vaccine doses earlier than other states by virtue of the pilot, nor will they receive any differential consideration.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.